Increasing awareness and knowledge of Alpha-gal Syndrome in the United States

Federal funding opportunity CDC-RFA-CK-26-0193 from Centers for Disease Control - NCEZID (Department of Health and Human Services).

Posted: May 19, 2026
Closes: July 9, 2026
Award ceiling: $1,000,000
Award floor: $25,000
Program funding: $10,000,000
Expected awards: 3
Cost sharing: No
Instrument: Cooperative Agreement
Assistance listing: 93.084
Category: Health
Archives: August 8, 2026

Program funding history

Awards made under Assistance Listing 93.084 across FY2024–FY2026, from public federal spending records.

FY2024 obligated: $11.2M
FY2025 obligated: $23.1M
FY2026 (to date) obligated: $219,999
Awards in window: 126

Top recipients: Emory University, Regents of the University of California, San Francisco, the, Puerto Rico Science, Technology, and Research Trust, Uganda Virus Research Institute, Pan American Health Organization

Source: USAspending.gov · refreshed July 2026

This opportunity is closed. Applications are no longer accepted. Similar open grants are listed below, and Grants Radar can alert you the next time funding like this posts.

Synopsis

The purpose of this NOFO is to improved awareness and knowledge of alpha-gal syndrome (AGS) in the United States. AGS is an emerging condition and is not nationally notifiable. This NOFO seeks to improve AGS surveillance, patient care, and public awareness and understanding. The NOFO strategies are to 1) SHARE - Formation of a network of AGS professionals to disseminate latest knowledge of AGS among stakeholders, including public health agencies, academic researchers, and advocacy groups, in order to improve patient care for AGS and the public health response. 2) EDUCATE - Create AGS communications targeted at the general public, AGS patients, or persons at higher risk for tick encounters (outdoor enthusiasts, dog owners, outdoor workers, etc.). Create communications targeted at healthcare providers including educational resources and training. 3) TRACK - Conduct active or enhances public health surveillance for AGS. This strategy could involve patient populations or geographical locations with limited access to specialized healthcare provider care.

Who can apply

City or township governments
Small businesses
Independent school districts
Native American tribal organizations (other than Federally recognized tribal governments)
Public housing authorities/Indian housing authorities
Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
State governments
County governments
Private institutions of higher education
Public and State controlled institutions of higher education
Special district governments
For profit organizations other than small businesses
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Bona fide agents are eligible to apply. For more information about bona fide agents, please see the CDC webpage on Expediting the Federal Grant Process with an Administrative Partner located at https://www.cdc.gov/publichealthgateway/grantsfunding/expediting.html#Q2

How to apply

Applications go through the official government listing. Grants Radar links you straight to the source.

View on Grants.gov

Agency contact: Centers for Disease Control - NCEZID · gqx1@cdc.gov · 770-488-2756

Get grants like this every Tuesday — free

One email a week: the biggest new federal grants and what’s closing soon. Unsubscribe in one click.

The free edition carries one clearly labeled sponsor slot. No spam, ever. Privacy

Similar grants

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
PAR-25-274 · National Institutes of Health · closes November 17, 2026
Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
PAR-24-276 · National Institutes of Health · closes July 14, 2026
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
PAR-25-268 · National Institutes of Health · closes November 17, 2026
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
PAR-25-155 · National Institutes of Health · closes October 19, 2026
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
PAR-25-144 · National Institutes of Health · closes January 7, 2028
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
PAR-25-143 · National Institutes of Health · closes January 7, 2028

Never miss a funding deadline again

Grants Radar sends AI-enriched alerts on federal grants and contracts matched to what you do. Founding seats are limited and locked for life.

Get funding alerts